PL1948176T3 - Diarylomoczniki do leczenia nadciśnienia płucnego - Google Patents

Diarylomoczniki do leczenia nadciśnienia płucnego

Info

Publication number
PL1948176T3
PL1948176T3 PL06828882T PL06828882T PL1948176T3 PL 1948176 T3 PL1948176 T3 PL 1948176T3 PL 06828882 T PL06828882 T PL 06828882T PL 06828882 T PL06828882 T PL 06828882T PL 1948176 T3 PL1948176 T3 PL 1948176T3
Authority
PL
Poland
Prior art keywords
pulmonary hypertension
treating pulmonary
diaryl ureas
diaryl
ureas
Prior art date
Application number
PL06828882T
Other languages
English (en)
Inventor
Peter Sandner
Hanna Tinel
Joachim Hütter
Bernd Riedl
Martina Klein
Ralph Schermuly
Friedrich Grimminger
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PL1948176T3 publication Critical patent/PL1948176T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06828882T 2005-11-10 2006-10-30 Diarylomoczniki do leczenia nadciśnienia płucnego PL1948176T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05024508 2005-11-10
EP05027449 2005-12-15
EP06007775 2006-04-13
PCT/EP2006/010405 WO2007054215A1 (en) 2005-11-10 2006-10-30 Diaryl ureas for treating pulmonary hypertension
EP06828882A EP1948176B1 (en) 2005-11-10 2006-10-30 Diaryl ureas for treating pulmonary hypertension

Publications (1)

Publication Number Publication Date
PL1948176T3 true PL1948176T3 (pl) 2011-05-31

Family

ID=37651281

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06828882T PL1948176T3 (pl) 2005-11-10 2006-10-30 Diarylomoczniki do leczenia nadciśnienia płucnego

Country Status (23)

Country Link
US (1) US20090176791A1 (pl)
EP (1) EP1948176B1 (pl)
JP (1) JP5075832B2 (pl)
KR (1) KR20080066030A (pl)
AR (1) AR057848A1 (pl)
AT (1) ATE493986T1 (pl)
AU (1) AU2006312713A1 (pl)
BR (1) BRPI0618524A2 (pl)
CA (1) CA2628847A1 (pl)
CU (1) CU23815A3 (pl)
DE (1) DE602006019468D1 (pl)
DK (1) DK1948176T3 (pl)
EC (1) ECSP088429A (pl)
IL (1) IL191010A0 (pl)
MY (1) MY144860A (pl)
NO (1) NO20082497L (pl)
NZ (1) NZ568031A (pl)
PL (1) PL1948176T3 (pl)
PT (1) PT1948176E (pl)
SV (1) SV2009002899A (pl)
TW (1) TW200735869A (pl)
UY (1) UY29902A1 (pl)
WO (1) WO2007054215A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Corporation .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
PT1626714E (pt) 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
ES2297490T3 (es) 2003-07-23 2008-05-01 Bayer Pharmaceuticals Corporation Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones.
JP5304241B2 (ja) 2005-03-07 2013-10-02 バイエル・ヘルスケア・エルエルシー 癌の処置用のオメガ−カルボキシアリール置換ジフェニルウレアを含む医薬組成物
US20090197922A1 (en) * 2006-01-24 2009-08-06 The University Of Chicago Compositions and methods for treating pulmonary hypertension
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
US8680124B2 (en) 2007-01-19 2014-03-25 Bayer Healthcare Llc Treatment of cancers with acquired resistance to kit inhibitors
JP2011525503A (ja) * 2008-06-25 2011-09-22 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 心不全を処置するためのジアリールウレア
MX2013003695A (es) 2010-10-01 2013-05-20 Bayer Ip Gmbh Combinaciones que contienen n-(2-arilamino) arilsulfonamida sustituida.
MX2013015058A (es) 2011-06-24 2014-01-20 Amgen Inc Antagonistas de melastatina 8 de potencial receptor transitorio y su uso en tratamientos.
CN103906733A (zh) 2011-06-24 2014-07-02 安姆根有限公司 Trpm8拮抗剂及其在治疗中的用途
US8586527B2 (en) * 2011-10-20 2013-11-19 Jaipal Singh Cerivastatin to treat pulmonary disorders
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
CA2897651C (en) 2013-01-10 2021-09-21 Pulmokine, Inc. Non-selective kinase inhibitors
CA2926793C (en) 2013-10-11 2022-11-22 Lawrence S. ZISMAN Spray-dry formulations for treating pulmonary arterial hypertension
US20160317542A1 (en) 2013-12-09 2016-11-03 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
US11057446B2 (en) 2015-05-14 2021-07-06 Bright Data Ltd. System and method for streaming content from multiple servers
CA3041679A1 (en) 2016-10-27 2018-05-03 Lawrence S. ZISMAN Combination therapy for treating pulmonary hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020065296A1 (en) * 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
US7928239B2 (en) * 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
DK1478358T3 (da) * 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
PT1626714E (pt) * 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr

Also Published As

Publication number Publication date
CA2628847A1 (en) 2007-05-18
CU20080082A7 (es) 2011-07-11
IL191010A0 (en) 2009-08-03
CU23815A3 (es) 2012-06-21
EP1948176B1 (en) 2011-01-05
ECSP088429A (es) 2008-07-30
DE602006019468D1 (de) 2011-02-17
AR057848A1 (es) 2007-12-19
ATE493986T1 (de) 2011-01-15
KR20080066030A (ko) 2008-07-15
PT1948176E (pt) 2011-03-07
BRPI0618524A2 (pt) 2011-09-06
AU2006312713A1 (en) 2007-05-18
UY29902A1 (es) 2007-06-29
SV2009002899A (es) 2009-04-28
EP1948176A1 (en) 2008-07-30
NZ568031A (en) 2011-06-30
JP5075832B2 (ja) 2012-11-21
MY144860A (en) 2011-11-30
JP2009514909A (ja) 2009-04-09
TW200735869A (en) 2007-10-01
NO20082497L (no) 2008-06-03
WO2007054215A1 (en) 2007-05-18
DK1948176T3 (da) 2011-04-18
US20090176791A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
IL191010A0 (en) Diaryl ureas for treating pulmonary hypertension
IL191178A0 (en) Diaryl urea for treating pulmonary hypertension
HK1255083A1 (zh) 用於治療肺動脈高壓的方法和組合物
HK1218393A1 (zh) 用於治療肺高壓的複合物
EP1940397A4 (en) METHOD FOR TREATING HYPERTONIA
EP1858455A4 (en) REPAIR OF THE VERTEBRAL COLUMN
GB0607675D0 (en) Business Strategy Transaction Router
GB2425290B (en) Bogie
GB0718306D0 (en) Security chip
HK1115921A1 (en) Oblique tourbillon
EP1922644A4 (en) DIRECT SIGNATURE WORKFLOW MANAGEMENT
AP2006003659A0 (en) Azabenzofuran substituted thioureas, inhibitors ofviral replication
IL185861A0 (en) Method and composition for treating mucosal disorders
EP1947484A4 (en) COATING DEVICE
EP1853274A4 (en) 2-METHYLENE-19-NOR- (20S-24S) -1ALPHA, 25-D HYDROXYVITAMINE-D2
EP1890690A4 (en) MAO-B INHIBITORS FOR TREATING OBESITY
ZA200805231B (en) Process for making diaryl carbonate
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
ZAA200501093S (en) Closures
ME01609B (me) Roflumilast za liječenje pulmonarne hipertenzije
GB0504018D0 (en) Quinazoline derivatives
GB0526422D0 (en) Authentication
GB0503306D0 (en) Authentication method
ZA200803979B (en) Diaryl urea for treating pulmonary hypertension
ZA200803920B (en) Diaryl ureas for treating pulmonary hypertension